2023浏览外网
CSGID has determined multiple structures from SARS-CoV-2, the coronavirus causing the COVID-19 disease and has also contributed to development of novel coronavirus research resources. CSGID scientists have created tool for visualisation and analysis of the SARS-CoV-2 protein structures with respect to mutational patterns. CSGID researchers are also participating in a consortium developing database of validated SARS-CoV-2 structural models providing accurate, carefully validated structures of potential drug targets.
CSGID is a consortium of
laboratories using state-of-the-art structural biology methods to determine the 3-D structures of proteins from
pathogens in the NIAID Category A-C priority lists and organisms causing emerging and re-emerging infectious diseases. We do this as a free service to the scientific community! Members of the scientific community are encouraged to
submit their targets of interest to CSGID by using our online form:
Submit/check your proposal now!
For more detailed information about our mission, please refer to the
CSGID brochure (pdf) and the
Overview.
Services
April, 2023: CSGID researchers have determined multiple proteins structures from SARS-CoV-2, the coronavirus causing COVID-19. This research has identified a new potential drug target for the SARS CoV-2 virus
CSGID is Soliciting Requests from the Scientific Community for Protein Structure Determination
This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contracts No. HHSN272200700058C, HHSN272201200026C, and HHSN272201700060C.